The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study

(2023) Lei Pang et al.   Journal of Inflammation Research

Parametric or nonparametric statistical tests: Considerations when choosing the most appropriate option for your data

(2022) Colleen M. Vrbin   CYTOPATHOLOGY

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry

(2021) A. Jeyaruban et al.   JOURNAL OF NEPHROLOGY

Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study

(2020) Tatsuo Hosoya et al.   Clinical and Experimental Nephrology

Effect of febuxostat on biochemical parameters of high fat diet-induced hyperlipidemia in rabbits

(2019) Mohammed Heikal et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients

(2019) Jing Wu et al.   International Journal of Rheumatic Diseases

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

(2019) Tatsuo Hosoya et al.   Clinical and Experimental Nephrology

Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study

(2018) Haibo Yu et al.   Clinical and Experimental Nephrology

Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study

(2017) Hsu-Wen Chou et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association

(2016) Samir G. Mallat et al.   CURRENT HYPERTENSION REPORTS

Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study

(2016) Young-Gun Kim et al.   Journal of Diabetes Research

Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease—A Propensity Score Analysis

(2015) Shunya Uchida et al.   PLoS One

Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction

(2014) Yugo Shibagaki et al.   HYPERTENSION RESEARCH

Uric Acid as a Target of Therapy in CKD

(2012) Diana I. Jalal et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study

(2012) Gianluca Trifirò et al.   ANNALS OF THE RHEUMATIC DISEASES

Hyperuricemia: a Reality in the Indian Obese

(2012) Carlyne Remedios et al.   OBESITY SURGERY

Efficacy of Benzbromarone in Hyperuricemic Patients Associated with Chronic Kidney Disease

(2011) S. Fujimori et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES